Home Data Calendar Blog

BVS

Tables

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Weighted Average Number Of Diluted Shares Outstanding 62.55 62.12 NA 61.67 61.48 60.48 NA 41.84 41.81 41.80 NA NA NA NA

Weighted Average Number Of Shares Outstanding Basic 62.55 62.12 NA 61.67 61.48 60.48 NA 41.84 41.81 41.80 NA NA NA NA

Earnings Per Share Basic -0.06 -2.24 -0.52 -1.76 -0.11 -0.19 0.00 -0.03 -0.10 -0.02 NA NA NA NA

Earnings Per Share Diluted -0.06 -2.24 -0.52 -1.76 -0.11 -0.19 0.00 -0.03 -0.10 -0.02 NA NA NA NA

Income Loss From Continuing Operations Per Basic Share -0.00 -0.00 NA NA -0.00 -0.00 NA NA NA NA NA NA NA NA

Income Loss From Continuing Operations Per Diluted Share -0.00 -0.00 NA NA -0.00 -0.00 NA NA NA NA NA NA NA NA

	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Weighted Average Number Of Diluted Shares Outstanding	62.55	62.12	NA	61.67	61.48	60.48	NA	41.84	41.81	41.80	NA	NA	NA	NA
Weighted Average Number Of Shares Outstanding Basic	62.55	62.12	NA	61.67	61.48	60.48	NA	41.84	41.81	41.80	NA	NA	NA	NA
Earnings Per Share Basic	-0.06	-2.24	-0.52	-1.76	-0.11	-0.19	0.00	-0.03	-0.10	-0.02	NA	NA	NA	NA
Earnings Per Share Diluted	-0.06	-2.24	-0.52	-1.76	-0.11	-0.19	0.00	-0.03	-0.10	-0.02	NA	NA	NA	NA
Income Loss From Continuing Operations Per Basic Share	-0.00	-0.00	NA	NA	-0.00	-0.00	NA	NA	NA	NA	NA	NA	NA	NA
Income Loss From Continuing Operations Per Diluted Share	-0.00	-0.00	NA	NA	-0.00	-0.00	NA	NA	NA	NA	NA	NA	NA	NA

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Revenue From Contract With Customer Excluding Assessed Tax 137.07 119.06 125.83 128.66 140.33 117.29 130.41 108.89 109.82 81.78 98.59 85.91 58.02 78.64

Revenues 137.07 119.06 125.83 128.66 140.33 117.29 130.41 108.89 109.82 81.78 98.59 85.91 58.02 78.64

Cost Of Goods And Services Sold 47.95 45.14 51.65 44.13 43.68 41.59 42.65 29.82 33.50 22.22 25.12 23.44 17.67 21.41

Gross Profit 89.12 73.92 74.19 84.53 96.65 75.70 87.77 79.07 76.31 59.56 73.47 62.46 40.35 57.24

Research And Development Expense 3.40 3.77 6.81 5.84 6.37 6.93 7.10 6.15 4.84 0.95 2.89 3.57 2.60 2.15

Selling General And Administrative Expense 74.84 80.86 77.67 79.19 89.62 86.12 80.88 69.64 69.05 34.69 61.97 50.30 40.53 40.28

Operating Income Loss 6.75 -92.06 -25.43 -200.85 -3.31 -21.45 -3.15 -1.05 -5.74 22.00 5.91 6.93 -4.59 12.99

Interest Income Expense Nonoperating Net -10.59 -9.69 -14.87 -9.89 -2.58 1.55 -0.96 -1.35 -1.68 2.88 -2.66 -1.88 -2.83 -2.38

Income Loss From Continuing Operations -3.68 -79.66 NA NA -6.97 -10.88 NA NA NA NA NA NA NA NA

Income Tax Expense Benefit 0.38 -0.15 -4.84 -41.78 1.24 -5.13 -2.73 -0.88 1.71 -0.07 0.89 0.37 -0.11 0.04

Profit Loss -4.73 -174.45 -44.87 -145.70 -8.01 -14.81 -1.89 -2.27 -10.78 -1.45 2.25 7.96 -5.98 10.49

Net Income Loss -3.68 -139.15 -31.93 -108.25 -7.25 -11.28 -0.36 -1.07 -4.13 24.94 2.78 8.46 -5.77 10.94

Comprehensive Income Net Of Tax -3.44 -64.20 -30.70 -108.82 -7.65 -11.82 -0.32 -1.33 -4.11 23.78 4.16 9.40 -5.55 10.47

Net Income Loss Available To Common Stockholders Basic NA NA -31.93 -108.25 -7.25 NA -0.36 -1.07 -4.13 NA NA NA NA NA

Net Income Loss Available To Common Stockholders Diluted NA NA -31.93 -108.25 -7.25 NA -0.36 -1.07 -4.13 NA NA NA NA NA

Goodwill Impairment Loss NA NA 0.00 189.20 NA NA NA NA NA NA NA NA NA NA

	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Revenue From Contract With Customer Excluding Assessed Tax	137.07	119.06	125.83	128.66	140.33	117.29	130.41	108.89	109.82	81.78	98.59	85.91	58.02	78.64
Revenues	137.07	119.06	125.83	128.66	140.33	117.29	130.41	108.89	109.82	81.78	98.59	85.91	58.02	78.64
Cost Of Goods And Services Sold	47.95	45.14	51.65	44.13	43.68	41.59	42.65	29.82	33.50	22.22	25.12	23.44	17.67	21.41
Gross Profit	89.12	73.92	74.19	84.53	96.65	75.70	87.77	79.07	76.31	59.56	73.47	62.46	40.35	57.24
Research And Development Expense	3.40	3.77	6.81	5.84	6.37	6.93	7.10	6.15	4.84	0.95	2.89	3.57	2.60	2.15
Selling General And Administrative Expense	74.84	80.86	77.67	79.19	89.62	86.12	80.88	69.64	69.05	34.69	61.97	50.30	40.53	40.28
Operating Income Loss	6.75	-92.06	-25.43	-200.85	-3.31	-21.45	-3.15	-1.05	-5.74	22.00	5.91	6.93	-4.59	12.99
Interest Income Expense Nonoperating Net	-10.59	-9.69	-14.87	-9.89	-2.58	1.55	-0.96	-1.35	-1.68	2.88	-2.66	-1.88	-2.83	-2.38
Income Loss From Continuing Operations	-3.68	-79.66	NA	NA	-6.97	-10.88	NA	NA	NA	NA	NA	NA	NA	NA
Income Tax Expense Benefit	0.38	-0.15	-4.84	-41.78	1.24	-5.13	-2.73	-0.88	1.71	-0.07	0.89	0.37	-0.11	0.04
Profit Loss	-4.73	-174.45	-44.87	-145.70	-8.01	-14.81	-1.89	-2.27	-10.78	-1.45	2.25	7.96	-5.98	10.49
Net Income Loss	-3.68	-139.15	-31.93	-108.25	-7.25	-11.28	-0.36	-1.07	-4.13	24.94	2.78	8.46	-5.77	10.94
Comprehensive Income Net Of Tax	-3.44	-64.20	-30.70	-108.82	-7.65	-11.82	-0.32	-1.33	-4.11	23.78	4.16	9.40	-5.55	10.47
Net Income Loss Available To Common Stockholders Basic	NA	NA	-31.93	-108.25	-7.25	NA	-0.36	-1.07	-4.13	NA	NA	NA	NA	NA
Net Income Loss Available To Common Stockholders Diluted	NA	NA	-31.93	-108.25	-7.25	NA	-0.36	-1.07	-4.13	NA	NA	NA	NA	NA
Goodwill Impairment Loss	NA	NA	0.00	189.20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Assets 836.96 887.40 1372.65 1398.02 1208.78 1197.14 1225.86 654.79 646.64 643.08 494.47 NA NA NA

Liabilities 603.62 647.04 1032.32 1018.88 688.59 675.22 692.07 424.29 427.27 422.79 350.31 NA NA NA

Liabilities And Stockholders Equity 836.96 887.40 1372.65 1398.02 1208.78 1197.14 1225.86 654.79 646.64 643.08 494.47 NA NA NA

Stockholders Equity 183.19 188.51 316.58 343.40 447.98 449.78 458.92 152.50 141.56 142.39 NA NA NA NA

	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Assets	836.96	887.40	1372.65	1398.02	1208.78	1197.14	1225.86	654.79	646.64	643.08	494.47	NA	NA	NA
Liabilities	603.62	647.04	1032.32	1018.88	688.59	675.22	692.07	424.29	427.27	422.79	350.31	NA	NA	NA
Liabilities And Stockholders Equity	836.96	887.40	1372.65	1398.02	1208.78	1197.14	1225.86	654.79	646.64	643.08	494.47	NA	NA	NA
Stockholders Equity	183.19	188.51	316.58	343.40	447.98	449.78	458.92	152.50	141.56	142.39	NA	NA	NA	NA

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Assets Current 260.64 308.66 272.57 271.08 277.16 245.40 263.10 246.08 290.06 270.72 211.79 NA NA NA

Cash And Cash Equivalents At Carrying Value 29.39 47.10 31.81 34.36 41.00 27.37 43.93 80.92 136.06 124.25 86.84 NA NA NA

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 29.39 47.10 31.84 34.38 41.00 82.65 99.21 130.92 138.07 129.45 86.84 72.48 126.24 130.28

Accounts Receivable Net Current 119.64 118.54 136.65 132.19 143.02 119.29 124.96 105.44 102.03 89.47 88.28 NA NA NA

Inventory Net 96.28 87.95 85.41 76.95 69.08 64.69 61.69 36.56 34.02 39.81 29.12 NA NA NA

Inventory Finished Goods 72.35 65.46 67.48 60.81 54.28 51.67 50.80 34.71 31.54 35.08 26.32 NA NA NA

Inventory Raw Materials And Supplies 26.44 24.73 19.77 17.38 16.09 14.32 12.21 3.38 4.20 5.80 3.67 NA NA NA

Prepaid Expense And Other Assets Current 15.34 17.19 18.68 27.56 24.06 28.76 27.24 23.15 15.94 11.99 7.55 NA NA NA

	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Assets Current	260.64	308.66	272.57	271.08	277.16	245.40	263.10	246.08	290.06	270.72	211.79	NA	NA	NA
Cash And Cash Equivalents At Carrying Value	29.39	47.10	31.81	34.36	41.00	27.37	43.93	80.92	136.06	124.25	86.84	NA	NA	NA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents	29.39	47.10	31.84	34.38	41.00	82.65	99.21	130.92	138.07	129.45	86.84	72.48	126.24	130.28
Accounts Receivable Net Current	119.64	118.54	136.65	132.19	143.02	119.29	124.96	105.44	102.03	89.47	88.28	NA	NA	NA
Inventory Net	96.28	87.95	85.41	76.95	69.08	64.69	61.69	36.56	34.02	39.81	29.12	NA	NA	NA
Inventory Finished Goods	72.35	65.46	67.48	60.81	54.28	51.67	50.80	34.71	31.54	35.08	26.32	NA	NA	NA
Inventory Raw Materials And Supplies	26.44	24.73	19.77	17.38	16.09	14.32	12.21	3.38	4.20	5.80	3.67	NA	NA	NA
Prepaid Expense And Other Assets Current	15.34	17.19	18.68	27.56	24.06	28.76	27.24	23.15	15.94	11.99	7.55	NA	NA	NA

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Property Plant And Equipment Gross NA NA 58.52 NA NA NA 46.09 NA NA NA 27.20 NA NA NA

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment NA NA 30.87 NA NA NA 23.10 NA NA NA 20.32 NA NA NA

Property Plant And Equipment Net NA NA 27.65 NA NA 24.86 22.98 10.30 8.96 8.08 6.88 NA NA NA

Long Term Investments 6.54 2.62 2.64 13.03 78.49 28.81 29.29 29.32 19.48 21.16 19.38 NA NA NA

Goodwill 7.46 7.46 13.76 15.36 143.16 147.97 147.62 52.88 52.13 53.53 49.80 NA NA NA

Intangible Assets Net Excluding Goodwill 505.22 516.04 1038.72 1055.60 666.52 681.37 695.19 248.79 257.85 271.04 191.65 NA NA NA

Finite Lived Intangible Assets Net 505.22 516.04 639.85 NA NA NA NA NA NA NA NA NA NA NA

	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Property Plant And Equipment Gross	NA	NA	58.52	NA	NA	NA	46.09	NA	NA	NA	27.20	NA	NA	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment	NA	NA	30.87	NA	NA	NA	23.10	NA	NA	NA	20.32	NA	NA	NA
Property Plant And Equipment Net	NA	NA	27.65	NA	NA	24.86	22.98	10.30	8.96	8.08	6.88	NA	NA	NA
Long Term Investments	6.54	2.62	2.64	13.03	78.49	28.81	29.29	29.32	19.48	21.16	19.38	NA	NA	NA
Goodwill	7.46	7.46	13.76	15.36	143.16	147.97	147.62	52.88	52.13	53.53	49.80	NA	NA	NA
Intangible Assets Net Excluding Goodwill	505.22	516.04	1038.72	1055.60	666.52	681.37	695.19	248.79	257.85	271.04	191.65	NA	NA	NA
Finite Lived Intangible Assets Net	505.22	516.04	639.85	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Liabilities Current 179.10 196.06 304.02 288.37 198.87 171.52 180.86 160.71 158.19 149.03 122.59 NA NA NA

Long Term Debt Current 11.32 41.32 33.06 31.30 22.55 20.29 18.04 15.00 15.00 15.00 15.00 NA NA NA

Accounts Payable Current 41.36 32.83 37.55 19.07 25.73 22.50 16.91 10.90 9.88 10.28 4.42 NA NA NA

Other Accrued Liabilities Current 18.89 22.20 17.55 21.35 21.71 20.18 21.38 20.87 18.46 18.96 18.24 NA NA NA

Taxes Payable Current 5.17 4.50 2.57 2.30 26.70 15.74 8.14 0.02 2.38 2.66 2.43 NA NA NA

Accrued Liabilities Current 121.75 115.77 111.95 116.89 146.76 124.80 131.47 107.55 105.25 89.65 88.19 NA NA NA

Other Liabilities Current 4.67 4.27 3.84 3.49 3.83 3.93 3.56 2.99 3.96 10.16 3.93 NA NA NA

Contract With Customer Liability Current NA NA 2.90 NA NA NA 2.40 NA NA NA NA NA NA NA

	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Liabilities Current	179.10	196.06	304.02	288.37	198.87	171.52	180.86	160.71	158.19	149.03	122.59	NA	NA	NA
Long Term Debt Current	11.32	41.32	33.06	31.30	22.55	20.29	18.04	15.00	15.00	15.00	15.00	NA	NA	NA
Accounts Payable Current	41.36	32.83	37.55	19.07	25.73	22.50	16.91	10.90	9.88	10.28	4.42	NA	NA	NA
Other Accrued Liabilities Current	18.89	22.20	17.55	21.35	21.71	20.18	21.38	20.87	18.46	18.96	18.24	NA	NA	NA
Taxes Payable Current	5.17	4.50	2.57	2.30	26.70	15.74	8.14	0.02	2.38	2.66	2.43	NA	NA	NA
Accrued Liabilities Current	121.75	115.77	111.95	116.89	146.76	124.80	131.47	107.55	105.25	89.65	88.19	NA	NA	NA
Other Liabilities Current	4.67	4.27	3.84	3.49	3.83	3.93	3.56	2.99	3.96	10.16	3.93	NA	NA	NA
Contract With Customer Liability Current	NA	NA	2.90	NA	NA	NA	2.40	NA	NA	NA	NA	NA	NA	NA

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Long Term Debt Noncurrent 374.57 404.26 385.01 393.10 351.43 348.04 339.64 162.44 166.08 169.73 173.38 NA NA NA

Deferred Income Tax Liabilities Net NA 0.35 154.00 159.30 98.89 116.02 133.52 47.69 48.41 48.96 3.36 NA NA NA

Minority Interest 50.15 51.85 23.75 35.75 72.21 72.14 74.86 77.99 77.81 77.89 NA NA NA NA

Other Liabilities Noncurrent 31.99 28.64 25.34 24.26 22.52 23.04 21.72 22.56 24.17 25.13 21.73 NA NA NA

Operating Lease Liability Noncurrent 12.49 13.46 14.80 14.16 15.90 16.21 15.04 15.22 15.99 16.40 14.11 NA NA NA

	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Long Term Debt Noncurrent	374.57	404.26	385.01	393.10	351.43	348.04	339.64	162.44	166.08	169.73	173.38	NA	NA	NA
Deferred Income Tax Liabilities Net	NA	0.35	154.00	159.30	98.89	116.02	133.52	47.69	48.41	48.96	3.36	NA	NA	NA
Minority Interest	50.15	51.85	23.75	35.75	72.21	72.14	74.86	77.99	77.81	77.89	NA	NA	NA	NA
Other Liabilities Noncurrent	31.99	28.64	25.34	24.26	22.52	23.04	21.72	22.56	24.17	25.13	21.73	NA	NA	NA
Operating Lease Liability Noncurrent	12.49	13.46	14.80	14.16	15.90	16.21	15.04	15.22	15.99	16.40	14.11	NA	NA	NA

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Stockholders Equity 183.19 188.51 316.58 343.40 447.98 449.78 458.92 152.50 141.56 142.39 NA NA NA NA

Stockholders Equity Including Portion Attributable To Noncontrolling Interest 233.34 240.36 340.33 379.15 520.19 521.92 533.79 230.50 219.36 220.28 NA NA NA NA

Additional Paid In Capital 490.60 492.48 481.92 478.03 473.80 467.94 465.27 158.48 146.20 142.92 NA NA NA NA

Retained Earnings Accumulated Deficit -308.14 -304.46 -165.31 -133.38 -25.13 -17.88 -6.60 -6.24 -5.17 -1.04 NA NA NA NA

Accumulated Other Comprehensive Income Loss Net Of Tax 0.66 0.41 -0.11 -1.34 -0.76 -0.36 0.18 0.20 0.47 0.45 NA NA NA NA

Minority Interest 50.15 51.85 23.75 35.75 72.21 72.14 74.86 77.99 77.81 77.89 NA NA NA NA

Stock Issued During Period Value New Issues 0.14 0.08 NA 0.48 2.18 2.08 NA 0.42 0.31 106.45 NA NA NA NA

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value -2.73 1.85 3.43 4.65 4.62 4.89 6.11 5.94 5.85 1.98 NA NA NA NA

	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Stockholders Equity	183.19	188.51	316.58	343.40	447.98	449.78	458.92	152.50	141.56	142.39	NA	NA	NA	NA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest	233.34	240.36	340.33	379.15	520.19	521.92	533.79	230.50	219.36	220.28	NA	NA	NA	NA
Additional Paid In Capital	490.60	492.48	481.92	478.03	473.80	467.94	465.27	158.48	146.20	142.92	NA	NA	NA	NA
Retained Earnings Accumulated Deficit	-308.14	-304.46	-165.31	-133.38	-25.13	-17.88	-6.60	-6.24	-5.17	-1.04	NA	NA	NA	NA
Accumulated Other Comprehensive Income Loss Net Of Tax	0.66	0.41	-0.11	-1.34	-0.76	-0.36	0.18	0.20	0.47	0.45	NA	NA	NA	NA
Minority Interest	50.15	51.85	23.75	35.75	72.21	72.14	74.86	77.99	77.81	77.89	NA	NA	NA	NA
Stock Issued During Period Value New Issues	0.14	0.08	NA	0.48	2.18	2.08	NA	0.42	0.31	106.45	NA	NA	NA	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value	-2.73	1.85	3.43	4.65	4.62	4.89	6.11	5.94	5.85	1.98	NA	NA	NA	NA

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Net Cash Provided By Used In Operating Activities 10.79 2.49 5.24 -0.70 2.94 -21.02 13.12 10.59 17.33 -18.04 25.45 20.84 7.82 17.69

Net Cash Provided By Used In Investing Activities 33.50 -15.07 -3.40 -56.33 -52.02 -4.67 -221.28 -13.19 -2.65 -46.65 -1.71 -17.76 -0.58 -0.45

Net Cash Provided By Used In Financing Activities -62.25 27.38 -5.44 50.65 7.66 9.21 176.31 -4.35 -6.12 107.53 -9.88 -57.12 -11.36 48.78

	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Net Cash Provided By Used In Operating Activities	10.79	2.49	5.24	-0.70	2.94	-21.02	13.12	10.59	17.33	-18.04	25.45	20.84	7.82	17.69
Net Cash Provided By Used In Investing Activities	33.50	-15.07	-3.40	-56.33	-52.02	-4.67	-221.28	-13.19	-2.65	-46.65	-1.71	-17.76	-0.58	-0.45
Net Cash Provided By Used In Financing Activities	-62.25	27.38	-5.44	50.65	7.66	9.21	176.31	-4.35	-6.12	107.53	-9.88	-57.12	-11.36	48.78

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Net Cash Provided By Used In Operating Activities 10.79 2.49 5.24 -0.70 2.94 -21.02 13.12 10.59 17.33 -18.04 25.45 20.84 7.82 17.69

Net Income Loss -3.68 -139.15 -31.93 -108.25 -7.25 -11.28 -0.36 -1.07 -4.13 24.94 2.78 8.46 -5.77 10.94

Profit Loss -4.73 -174.45 -44.87 -145.70 -8.01 -14.81 -1.89 -2.27 -10.78 -1.45 2.25 7.96 -5.98 10.49

Depreciation Depletion And Amortization 14.60 16.47 23.16 18.78 12.38 12.48 11.69 8.52 7.48 7.18 6.85 7.28 7.25 7.26

Increase Decrease In Other Operating Capital Net -0.17 2.13 -9.41 2.03 -5.35 1.53 0.90 0.71 NA NA NA NA NA NA

Increase Decrease In Accounts Receivable 1.83 -13.16 5.18 -8.32 25.57 -4.42 6.90 3.78 11.98 -2.61 7.30 13.27 -13.28 -3.35

Increase Decrease In Inventories 7.78 5.29 10.00 6.01 2.94 -0.33 -1.69 2.42 -6.96 3.05 -6.48 0.68 4.93 1.40

Share Based Compensation -2.73 1.85 3.43 4.65 4.62 4.89 6.11 5.94 5.85 1.94 NA NA NA NA

	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Net Cash Provided By Used In Operating Activities	10.79	2.49	5.24	-0.70	2.94	-21.02	13.12	10.59	17.33	-18.04	25.45	20.84	7.82	17.69
Net Income Loss	-3.68	-139.15	-31.93	-108.25	-7.25	-11.28	-0.36	-1.07	-4.13	24.94	2.78	8.46	-5.77	10.94
Profit Loss	-4.73	-174.45	-44.87	-145.70	-8.01	-14.81	-1.89	-2.27	-10.78	-1.45	2.25	7.96	-5.98	10.49
Depreciation Depletion And Amortization	14.60	16.47	23.16	18.78	12.38	12.48	11.69	8.52	7.48	7.18	6.85	7.28	7.25	7.26
Increase Decrease In Other Operating Capital Net	-0.17	2.13	-9.41	2.03	-5.35	1.53	0.90	0.71	NA	NA	NA	NA	NA	NA
Increase Decrease In Accounts Receivable	1.83	-13.16	5.18	-8.32	25.57	-4.42	6.90	3.78	11.98	-2.61	7.30	13.27	-13.28	-3.35
Increase Decrease In Inventories	7.78	5.29	10.00	6.01	2.94	-0.33	-1.69	2.42	-6.96	3.05	-6.48	0.68	4.93	1.40
Share Based Compensation	-2.73	1.85	3.43	4.65	4.62	4.89	6.11	5.94	5.85	1.94	NA	NA	NA	NA

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Net Cash Provided By Used In Investing Activities 33.50 -15.07 -3.40 -56.33 -52.02 -4.67 -221.28 -13.19 -2.65 -46.65 -1.71 -17.76 -0.58 -0.45

Payments To Acquire Property Plant And Equipment 1.40 3.56 3.40 1.65 2.03 2.96 2.80 1.93 1.27 1.37 1.76 1.28 0.75 0.30

		2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Net Cash Provided By Used In Investing Activities		33.50	-15.07	-3.40	-56.33	-52.02	-4.67	-221.28	-13.19	-2.65	-46.65	-1.71	-17.76	-0.58	-0.45
Payments To Acquire Property Plant And Equipment		1.40	3.56	3.40	1.65	2.03	2.96	2.80	1.93	1.27	1.37	1.76	1.28	0.75	0.30

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Net Cash Provided By Used In Financing Activities -62.25 27.38 -5.44 50.65 7.66 9.21 176.31 -4.35 -6.12 107.53 -9.88 -57.12 -11.36 48.78

		2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Net Cash Provided By Used In Financing Activities		-62.25	27.38	-5.44	50.65	7.66	9.21	176.31	-4.35	-6.12	107.53	-9.88	-57.12	-11.36	48.78

2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-27 2020-03-28

Revenues 137.07 119.06 125.83 128.66 140.33 117.29 130.41 108.89 109.82 81.78 98.59 85.91 58.02 78.64

Pain Treatments NA NA NA NA 63.91 52.05 NA NA 56.70 41.53 NA NA NA NA

Restorative Therapies NA NA NA NA 39.90 34.36 36.77 30.48 32.51 21.82 27.19 20.00 17.97 23.46

Surgical Solutions NA NA NA NA 36.52 30.88 NA NA 20.60 18.43 NA NA NA NA

Pain Treatments,US 55.62 40.99 41.89 47.01 58.05 47.87 56.19 55.96 NA NA NA NA NA NA

Pain Treatments, Non Us 6.02 5.33 6.37 5.09 5.86 4.18 6.55 4.67 NA NA NA NA NA NA

Restorative Therapies,US 31.84 32.49 31.74 38.10 35.43 28.95 31.52 25.63 NA NA NA NA NA NA

Restorative Therapies, Non Us 4.77 5.61 6.49 4.05 4.47 5.41 5.25 4.84 NA NA NA NA NA NA

Surgical Solutions,US 33.39 30.50 34.94 31.18 32.82 27.26 27.46 17.57 NA NA NA NA NA NA

Surgical Solutions, Non Us 5.42 4.14 4.41 3.24 3.69 3.62 3.45 0.21 NA NA NA NA NA NA

US 120.85 103.98 108.57 116.29 126.31 104.08 115.17 99.16 98.68 74.54 89.67 78.89 53.17 71.97

Non Us 16.22 15.08 17.26 12.37 14.02 13.21 15.24 9.73 11.13 7.24 8.92 7.02 4.85 6.67

Revenue From Contract With Customer Excluding Assessed Tax 137.07 119.06 125.83 128.66 140.33 117.29 130.41 108.89 109.82 81.78 98.59 85.91 58.02 78.64

Pain Treatments NA NA NA NA 63.91 52.05 NA NA 56.70 41.53 NA NA NA NA

Restorative Therapies NA NA NA NA 39.90 34.36 36.77 30.48 32.51 21.82 27.19 20.00 17.97 23.46

Surgical Solutions NA NA NA NA 36.52 30.88 NA NA 20.60 18.43 NA NA NA NA

Pain Treatments,US 55.62 40.99 41.89 47.01 58.05 47.87 56.19 55.96 NA NA NA NA NA NA

Pain Treatments, Non Us 6.02 5.33 6.37 5.09 5.86 4.18 6.55 4.67 NA NA NA NA NA NA

Restorative Therapies,US 31.84 32.49 31.74 38.10 35.43 28.95 31.52 25.63 NA NA NA NA NA NA

Restorative Therapies, Non Us 4.77 5.61 6.49 4.05 4.47 5.41 5.25 4.84 NA NA NA NA NA NA

Surgical Solutions,US 33.39 30.50 34.94 31.18 32.82 27.26 27.46 17.57 NA NA NA NA NA NA

Surgical Solutions, Non Us 5.42 4.14 4.41 3.24 3.69 3.62 3.45 0.21 NA NA NA NA NA NA

US 120.85 103.98 108.57 116.29 126.31 104.08 115.17 99.16 98.68 74.54 89.67 78.89 53.17 71.97

Non Us 16.22 15.08 17.26 12.37 14.02 13.21 15.24 9.73 11.13 7.24 8.92 7.02 4.85 6.67

	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-04-03	2020-12-31	2020-09-26	2020-06-27	2020-03-28
Revenues	137.07	119.06	125.83	128.66	140.33	117.29	130.41	108.89	109.82	81.78	98.59	85.91	58.02	78.64
Pain Treatments	NA	NA	NA	NA	63.91	52.05	NA	NA	56.70	41.53	NA	NA	NA	NA
Restorative Therapies	NA	NA	NA	NA	39.90	34.36	36.77	30.48	32.51	21.82	27.19	20.00	17.97	23.46
Surgical Solutions	NA	NA	NA	NA	36.52	30.88	NA	NA	20.60	18.43	NA	NA	NA	NA
Pain Treatments,US	55.62	40.99	41.89	47.01	58.05	47.87	56.19	55.96	NA	NA	NA	NA	NA	NA
Pain Treatments, Non Us	6.02	5.33	6.37	5.09	5.86	4.18	6.55	4.67	NA	NA	NA	NA	NA	NA
Restorative Therapies,US	31.84	32.49	31.74	38.10	35.43	28.95	31.52	25.63	NA	NA	NA	NA	NA	NA
Restorative Therapies, Non Us	4.77	5.61	6.49	4.05	4.47	5.41	5.25	4.84	NA	NA	NA	NA	NA	NA
Surgical Solutions,US	33.39	30.50	34.94	31.18	32.82	27.26	27.46	17.57	NA	NA	NA	NA	NA	NA
Surgical Solutions, Non Us	5.42	4.14	4.41	3.24	3.69	3.62	3.45	0.21	NA	NA	NA	NA	NA	NA
US	120.85	103.98	108.57	116.29	126.31	104.08	115.17	99.16	98.68	74.54	89.67	78.89	53.17	71.97
Non Us	16.22	15.08	17.26	12.37	14.02	13.21	15.24	9.73	11.13	7.24	8.92	7.02	4.85	6.67
Revenue From Contract With Customer Excluding Assessed Tax	137.07	119.06	125.83	128.66	140.33	117.29	130.41	108.89	109.82	81.78	98.59	85.91	58.02	78.64
Pain Treatments	NA	NA	NA	NA	63.91	52.05	NA	NA	56.70	41.53	NA	NA	NA	NA
Restorative Therapies	NA	NA	NA	NA	39.90	34.36	36.77	30.48	32.51	21.82	27.19	20.00	17.97	23.46
Surgical Solutions	NA	NA	NA	NA	36.52	30.88	NA	NA	20.60	18.43	NA	NA	NA	NA
Pain Treatments,US	55.62	40.99	41.89	47.01	58.05	47.87	56.19	55.96	NA	NA	NA	NA	NA	NA
Pain Treatments, Non Us	6.02	5.33	6.37	5.09	5.86	4.18	6.55	4.67	NA	NA	NA	NA	NA	NA
Restorative Therapies,US	31.84	32.49	31.74	38.10	35.43	28.95	31.52	25.63	NA	NA	NA	NA	NA	NA
Restorative Therapies, Non Us	4.77	5.61	6.49	4.05	4.47	5.41	5.25	4.84	NA	NA	NA	NA	NA	NA
Surgical Solutions,US	33.39	30.50	34.94	31.18	32.82	27.26	27.46	17.57	NA	NA	NA	NA	NA	NA
Surgical Solutions, Non Us	5.42	4.14	4.41	3.24	3.69	3.62	3.45	0.21	NA	NA	NA	NA	NA	NA
US	120.85	103.98	108.57	116.29	126.31	104.08	115.17	99.16	98.68	74.54	89.67	78.89	53.17	71.97
Non Us	16.22	15.08	17.26	12.37	14.02	13.21	15.24	9.73	11.13	7.24	8.92	7.02	4.85	6.67

Plots across concepts

IncomeStatement

Expenses

Balance Sheet

Assets

Current Assets

NonCurrent Assets

PropertyPlantAndEquipmentNet

Liabilities

Current Liabilities

Noncurrent Liabilities

Stockholders Equity

CashFlow

NetCashProvidedByUsedInOperatingActivities

NetCashProvidedByUsedInInvestingActivities

NetCashProvidedByUsedInFinancingActivities

OperatingLeaseLiability

NonoperatingIncomeExpense

LesseeOperatingLeaseLiabilityPaymentsDue

FiniteLivedIntangibleAssets

InventoryNet

AccountsReceivable

Line plots across dimensions of each concept

TTM Greenblatt ROC
_
(None,)

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical
(None,)

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)

us-gaap:Revenues
us-gaap:StatementGeographical
(None,)

us-gaap:Revenues
us-gaap:ProductOrService
(None,)

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
(None,)

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:PlanName
(None,)

us-gaap:ProfitLoss
us-gaap:StatementEquityComponents
(None,)

us-gaap:Liabilities
us-gaap:Restatement
(None,)

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)

us-gaap:Goodwill
us-gaap:ReportingUnit
(None,)

us-gaap:AccountsPayableCurrent
us-gaap:ConcentrationRiskByBenchmark, us-gaap:ConcentrationRiskByType, us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplier
('us-gaap:AccountsPayable', 'us-gaap:SupplierConcentrationRisk', None)

us-gaap:DeferredIncomeTaxLiabilitiesNet
us-gaap:Restatement
(None,)

us-gaap:MinorityInterest
us-gaap:Restatement
(None,)

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:Restatement
(None,)

us-gaap:AdditionalPaidInCapital
us-gaap:Restatement
(None,)